Johnson & Johnson’s Baby Powder and Shower to Shower May Cause Ovarian Cancer
Three times now, juries have found Johnson & Johnson negligent in warning consumers of the dangers of talc based products like Johnson & Johnson’s Baby Powder and Shower to Shower. Diane Berg, a Sioux Falls, 
South Dakota woman, won her case against Johnson & Johnson but was not awarded any damages, unlike the two recent cases in St. Louis.
At the age of 49, Diane had been diagnosed with advanced ovarian cancer despite lacking common risk factors such as infertility or endometriosis. She did however use Johnson & Johnson’s Baby Powder between her legs every day for 30 years. For many women who use talcum powder products like baby powder, the talc particles can travel through the reproductive tract and embed themselves in the ovaries where they act as irritants, causing cancer cells to develop and grow. There has been evidence of this occurrence since at least 1982 but Johnson & Johnson has not put any kind of warning on their baby powder or Shower to Shower packaging.
Talc is a naturally occurring mineral, and is often mined near asbestos sources. Most forms of talc contained asbestos until the 1973. Baby powder has been known to cause respiratory issues for infants, but studies have shown that talc fibers can cause inflammation in the lungs for people of all ages. Once this inflammation occurs, there is no remedy.
Thousands of women from all over the country are now coming forward and claiming they too were diagnosed with ovarian cancer after using Johnson & Johnson’s Baby Powder or Shower to Shower. Johnson & Johnson plans to appeal the recent cases, they are still standing behind the safety of their products. If you or your loved one used Johnson & Johnson Baby Shower or Shower to Shower and were diagnosed with ovarian cancer, you may be eligible for compensation. Johnson & Johnson has already been ordered to pay over $127 million in damages to victims. Contact the Hollis Law Firm today for a free and confidential talcum powder lawsuit review.
